drugset / Trial / NCT03662022

Summary

This is a cluster randomized trial on effectiveness of different modalities of Single Double Dose of Rifampicin Post-Exposure Prophylaxis (SDDR-PEP) for leprosy in the Comoros (Anjouan and Mohéli) and Madagascar. The study aims to identify which approach to the selection of contacts for post exposure prophylaxis is most effective to reduce incident leprosy, and to Interrupt ongoing transmission from asymptomatic persons in the process of developing multibacillary leprosy.

Timeline

Start
2019-01-02
Primary completion
2023-01-17
Completion
2023-01-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifampin Small molecule 20 mg/kg

Indications